Two glutathione S-transferase inhibitors from Radix Angelicae sinensis

Phytotherapy Research

Volumn 25, Issue 2, 2011, Pages 284-289

  Huang, Feng ^a   Li, Shaojing ^b   Lu, Xinhua ^c   Liu, Ailin ^d   Du, Guanhua ^d   Shi, Ganggang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c North China Pharmaceutical Corporation   (China)

^d INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

11 angeloylsenkyunolide F; cancer; glutathione S transferase; multidrug resistance; Radix Angelicae sinensis; Tokinolide B

Indexed keywords

11 ANGELOYLSENKYUNOLIDE F; ANGELICA ROOT; DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE INHIBITOR; TOKINOLIDE B; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CYTOTOXICITY; DRUG ISOLATION; HIGH THROUGHPUT SCREENING; IC 50; MOLECULAR DOCKING; NONHUMAN;

ANGELICA SINENSIS; APOPTOSIS; BENZOFURANS; CELL LINE; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, MOLECULAR; PLANT EXTRACTS; PLANT ROOTS;

EID: 79551674851     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3197     Document Type: Article

References (24)

1. Bradley RR, Cunniff PJ, Pereira BJ, Jaber BL., 1999. Hematopoietic effect of Radix angelicae sinensis in a hemodialysis patient. Am J Kidney Dis 34: 349-354.
2. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB., 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47: 936-942. (Pubitemid 17027905)
3. Chen QC, Lee J, Jin W, et al,. 2007. Cytotoxic constituents from angelicae sinensis radix. Arch Pharm Res 30: 565-569.
4. Habig WH, Pabst MJ, Jakoby WB., 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
5. Hsieh CC, Lin WC, Lee MR, et al,. 2003. Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice. Immunopharmacol Immunotoxicol 25: 259-271.
6. Huang M, Jin J, Sun H, Liu GT., 2008. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother Pharmacol 62: 1015-1026.
7. Johansson K, Ahlen K, Rinaldi R, Sahlander K, Siritantikorn A, Morgenstern R., 2007. Microsomal glutathione transferase 1 in anticancer drug resistance. Carcinogenesis 28: 465-470. (Pubitemid 46321864)
8. Lage H., 2008. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 65: 3145-3167.
9. Li SL, Chan SS, Lin G, et al,. 2003. Simultaneous analysis of seventeen chemical ingredients of Ligusticum chuanxiong by on-line high performance liquid chromatography-diode array detector-mass spectrometry. Planta Med 69: 445-451.
10. Lu XH, Liang H, Zhao YY., 2003. Isolation and identification of the ligustilide compounds from the root of Angelica sinensis. Zhongguo Zhong Yao Za Zhi 28: 423-425.
11. Mellor HR, Callaghan R., 2008. Resistance to chemotherapy in cancer: a complex and integrated cellular response. Pharmacology 81: 275-300.
12. Nabekura T, Yamaki T, Ueno K, Kitagawa S., 2008. Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1. Biochem Biophys Res Commun 369: 363-368.
13. O'Brien ML, Tew KD., 1996. Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A: 967-978.
14. O'Connor R, Clynes M, Dowling P, O'Donovan N, O'Driscoll L., 2007. Drug resistance in cancer-searching for mechanisms, markers and therapeutic agents. Expert Opin Drug Metab Toxicol 3: 805-817.
15. Ramachandran C, Mead D, Wellham LL, Sauerteig A, Krishan A., 1995. Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse. Biochem Pharmacol 49: 545-552.
16. Shen J, Zhang W, Wu J, Zhu Y., 2008. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells. Int J Hyperthermia 24: 151-159.
17. Tew KD, Bomber AM, Hoffman SJ., 1988. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48: 3622-3625.
18. Tew KD, Dutta S, Schultz M., 1997. Inhibitors of glutathione S-transferases as therapeutic agents. Adv Drug Deliv Rev 26: 91-104.
19. Townsend DM, Findlay VL, Tew KD., 2005. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol 401: 287-307.
20. Townsend DM, Tew KD., 2003. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 22: 7369-7375.
21. Tsuruo T., 1988. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 79: 285-296.
22. Ullah MF., 2008. Cancer multidrug resistance: a major impediment to effective chemotherapy. Asian Pac J Cancer Prev 9: 1-6.
23. Um Y, Cho S, Woo HB, et al,. 2008. Synthesis of curcumin mimics with multidrug resistance reversal activities. Bioorg Med Chem 16: 3608-3615.
24. Zhao G, Yu T, Wang R, Wang X, Jing Y., 2005. Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition. Bioorg Med Chem 13: 4056-4062.